154 related articles for article (PubMed ID: 3335282)
21. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
Dembinski A; Jaworek J; Konturek PK; Konturek SJ; Warzecha Z
J Physiol; 1989 Apr; 411():419-35. PubMed ID: 2614728
[TBL] [Abstract][Full Text] [Related]
22. Camostate- and caerulein-induced delay of gastric emptying in the rat: effect of CCK receptor antagonists.
Varga G; Scarpignato C
Eur J Pharmacol; 1996 Jun; 306(1-3):153-9. PubMed ID: 8813627
[TBL] [Abstract][Full Text] [Related]
23. Mediation of trypsin inhibitor-induced pancreatic hypersecretion by secretin and cholecystokinin in rats.
Watanabe S; Takeuchi T; Chey WY
Gastroenterology; 1992 Feb; 102(2):621-8. PubMed ID: 1732130
[TBL] [Abstract][Full Text] [Related]
24. Role of ornithine decarboxylase and polyamines in camostate (Foy-305)-induced pancreatic growth in rats.
Löser C; Fölsch UR; Cleffmann U; Nustede R; Creutzfeldt W
Digestion; 1989; 43(1-2):98-112. PubMed ID: 2509268
[TBL] [Abstract][Full Text] [Related]
25. Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion.
Göke B; Stöckmann F; Müller R; Lankisch PG; Creutzfeldt W
Digestion; 1984; 30(3):171-8. PubMed ID: 6209186
[TBL] [Abstract][Full Text] [Related]
26. Endocrine and exocrine pancreatic function after camostate-induced growth of the organ.
von Schönfeld J; Rünzi M; Goebell H; Müller MK
Experientia; 1995 Jun; 51(6):556-60. PubMed ID: 7607295
[TBL] [Abstract][Full Text] [Related]
27. Effect of a low-molecular weight serine proteinase inhibitor (camostate) on amylase release from isolated pancreatic acini.
Göke B; Leferink J; Göke R; Adler G
Res Exp Med (Berl); 1989; 189(1):33-8. PubMed ID: 2469115
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of pancreatic secretion in man by a protease inhibitor (camostate).
Adler G; Müllenhoff A; Koop I; Bozkurt T; Göke B; Beglinger C; Arnold R
Eur J Clin Invest; 1988 Feb; 18(1):98-104. PubMed ID: 3130267
[TBL] [Abstract][Full Text] [Related]
29. Effect of a new CCK-A receptor antagonist, dexloxiglumide, on the exocrine pancreas in the rat.
Varga G; Kisfalvi K; D'Amato M; Scarpignato C
J Physiol Paris; 1997; 91(3-5):257-64. PubMed ID: 9403804
[TBL] [Abstract][Full Text] [Related]
30. Effects of a cholecystokinin receptor antagonist on rat exocrine pancreatic response to raw soya flour.
Sundaram S; Dayan AD
Hum Exp Toxicol; 1991 May; 10(3):179-82. PubMed ID: 1678946
[TBL] [Abstract][Full Text] [Related]
31. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.
Otsuki M; Fujii M; Nakamura T; Tani S; Okabayashi Y
Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829
[TBL] [Abstract][Full Text] [Related]
32. Age-dependent influence of octreotide on stimulated pancreatic growth in the postnatal period of rats.
Kisfalvi K; Friess H; Büchler MW; Tulassay Z; Varga G; Papp M
Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):69-74. PubMed ID: 8900912
[TBL] [Abstract][Full Text] [Related]
33. Intracellular mechanism responsible for reduced enzyme secretion from camostate-induced hypertrophied pancreas.
Herzig KH; May D; Louie DS; Takahashi T; Göke B; Owyang C
Digestion; 1990; 46 Suppl 2():195-201. PubMed ID: 1702070
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
[TBL] [Abstract][Full Text] [Related]
35. Precocious alteration of digestive enzyme activities in small intestine and pancreas by chronic oral administration of protease inhibitor in suckling rats.
Harada E; Syuto B
Comp Biochem Physiol A Comp Physiol; 1991; 100(2):467-72. PubMed ID: 1685962
[TBL] [Abstract][Full Text] [Related]
36. Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats.
Otsuki M; Tani S; Okabayashi Y; Fuji M; Nakamura T; Fujisawa T; Itoh H
Dig Dis Sci; 1990 Feb; 35(2):242-50. PubMed ID: 1689237
[TBL] [Abstract][Full Text] [Related]
37. Feedback control of pancreatic secretion in rats. Role of gastric acid secretion.
Bilski J; Konturek PK; Krzyzek E; Konturek SJ
J Physiol Pharmacol; 1992 Sep; 43(3):237-57. PubMed ID: 1493255
[TBL] [Abstract][Full Text] [Related]
38. Effect of atropine on feedback regulation of pancreatic secretion in rats.
Weidenbach H; Printz H; Göke B; Koop I; Schafmayer A; Adler G
Res Exp Med (Berl); 1989; 189(3):221-8. PubMed ID: 2473503
[TBL] [Abstract][Full Text] [Related]
39. Adaptation of the human pancreas to inhibition of luminal proteolytic activity.
Friess H; Kleeff J; Isenmann R; Malfertheiner P; Büchler MW
Gastroenterology; 1998 Aug; 115(2):388-96. PubMed ID: 9679044
[TBL] [Abstract][Full Text] [Related]
40. Cholecystokinin is responsible for growth of the pancreas after pancreaticobiliary diversion in rats.
Gasslander T; Axelson J; Håkanson R; Ihse I; Lilja I; Rehfeld JF
Scand J Gastroenterol; 1990 Oct; 25(10):1060-5. PubMed ID: 2263879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
